Understanding Competition in the Genomic Urine Testing Market: Key Players and Differentiators

Genomic Urine Testing Market Report_2026

The Business Research Company's Genomic Urine Testing Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, May 11, 2026 /EINPresswire.com/ -- "The genomic urine testing market is dominated by a mix of global diagnostics companies, specialized molecular testing providers, and biotechnology firms. Companies are focusing on advanced genomic analysis technologies, non-invasive diagnostic testing solutions, precision biomarker identification, and regulatory-compliant laboratory workflows to strengthen market presence and maintain stringent clinical and quality standards. Emphasis on early disease detection, accuracy of test results, and integration of digital health data management systems remains central to competitive positioning. Understanding the competitive landscape is essential for stakeholders seeking growth opportunities, technological innovation, and strategic partnerships within the rapidly evolving molecular diagnostics and precision medicine sector.

Which Market Player Is Leading The Genomic Urine Testing Market?
•According to our research, MDxHealth SA led global sales in 2024 with a 2% market share. The company’s molecular diagnostics division, which is directly involved in the genomic urine testing market, provides a wide range of non-invasive genomic tests, biomarker-based diagnostic solutions, and precision medicine tools that support cancer detection, disease monitoring, and clinical decision-making environments.

Who Are The Major Players In The Genomic Urine Testing Market?
Major companies operating in the genomic urine testing market are MDxHealth SA, Pacific Edge Ltd., Nucleix Ltd., miR Scientific, LynxDx Inc., Convergent Genomics Inc., Predicine Inc., Thermo Fisher Scientific Inc., Source BioScience Ltd., Illumina Inc., ARUP Laboratories, Codex Genetics, Eurofins Scientific SE, Laboratory Corporation of America Holdings.

How Concentrated Is The Genomic Urine Testing Market?
•The market is fragmented, with the top 10 players accounting for 6% of total market revenue in 2024. This level of concentration reflects moderate technological and regulatory entry barriers, driven by stringent clinical validation requirements, compliance with diagnostic and regulatory guidelines, complexity of genomic testing technologies, and the need for accuracy and reliability in molecular diagnostics and precision medicine environments. Leading players such as MDxHealth SA, Pacific Edge Ltd., Nucleix Ltd., miR Scientific, LynxDx Inc., Convergent Genomics Inc., Predicine Inc., Thermo Fisher Scientific Inc., Source BioScience Ltd., and Illumina Inc. hold notable market shares through diversified genomic testing portfolios, established clinical and research partnerships, global diagnostic networks, and continuous innovation in non-invasive urine-based genomic testing technologies. As demand for advanced early disease detection tools, precision oncology diagnostics, and regulated molecular testing solutions grows, strategic collaborations, product innovation, and regional expansion are expected to strengthen the competitive positioning of these leading companies in the market.

•Leading companies include:
oMDxHealth SA (2%)
oPacific Edge Ltd. (1%)
oNucleix Ltd. (0.5%)
omiR Scientific (0.5%)
oLynxDx Inc. (0.5%)
oConvergent Genomics Inc. (0.5%)
oPredicine Inc. (0.4%)
oThermo Fisher Scientific Inc. (0.4%)
oSource BioScience Ltd. (0.4%)
oIllumina Inc. (0.3%)

Request A Free Sample Of The Genomic Urine Testing Market Report
https://www.thebusinessresearchcompany.com/sample_request?id=23408&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=May_PR

Who Are The Key Raw Material Suppliers In The Genomic Urine Testing Market?
•Major raw material suppliers in the genomic urine testing market include Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Revvity Inc., Eurofins Scientific SE, BGI Genomics Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Exact Sciences Corporation, Guardant Health Inc., Foundation Medicine Inc., Natera Inc., Veracyte Inc., Invitae Corporation, 10x Genomics Inc., ArcherDX Inc., and Bio-Techne Corporation.

Who Are The Major Wholesalers And Distributors In The Genomic Urine Testing Market?
•Major wholesalers and distributors in the genomic urine testing market include McKesson Corporation, Cardinal Health Inc., Cencora, Medline Industries LP, Henry Schein Inc., Owens & Minor Inc., Fisher Scientific International Inc., VWR International LLC, Patterson Companies Inc., and Midland Scientific Inc.

Who Are The Major End Users Of The Genomic Urine Testing Market?
•Major end users in the genomic urine testing market include Mount Sinai Health System, Kaiser Permanente, Labcorp, Quest Diagnostics Incorporated, Sonic Healthcare Limited, ARUP Laboratories, Cleveland Clinic Laboratories, 23andMe Inc., and Singapore General Hospital.

What Are The Major Competitive Trends In The Market?
•AI-driven metagenomic testing is transforming the genomic urine testing market by improving pathogen detection accuracy, enabling antimicrobial resistance profiling, and supporting precision treatment decisions.
•Example: In September 2025, Biotia Inc. launched BIOTIA-ID urine test, a next-generation sequencing and AI-based diagnostic solution for recurrent urinary tract infections.
•Its ability to detect over 40 uropathogens, support at-home sample collection, and integrate virtual consultations enhances diagnostic reliability and enables faster, personalized treatment pathways.

Which Strategies Are Companies Adopting To Stay Ahead?
•Advancing Genomic Urine Testing Supporting Early Detection, Precision Diagnostics, And Personalized Care
•Leveraging Advanced Sequencing And Molecular Assays Improving Accuracy, Throughput, And Clinical Outcomes
•Expanding And Modernizing Laboratory Infrastructure Strengthening Urine Genomic Analysis And Biomarker Detection
•Integrating AI Driven Analytics Enhancing Accuracy, Automation, And Efficiency In Urine Genomic Testing

Access The Detailed Genomic Urine Testing Market Report Here
https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=May_PR

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 17,500 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.

Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.

Contact Us:
The Business Research Company
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email: marketing@tbrc.info

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.